(UK) ADHD/ASD provider sees business double in size; 5-fold increase in ASD referrals

June 24, 2026, The Star:  Health group's growth fuels ADHD and autism debate

A Sheffield healthcare provider specialising in neurodiversity, mental health and addiction has almost doubled in size during the last year as demand for ADHD and autism support continues to rise across the UK.

Montrose Health Group, regulated by the Care Quality Commission (CQC), has reported a surge in demand following the launch of its dedicated ADHD and autism service and a major expansion of its clinical and operational team.

The business has doubled in size, opened an additional Sheffield clinic and operational hub, and recruited 15 new members of staff.

But for Montrose Health Group founder and CEO Jonathan Edgeley his business’s growth reflects a healthcare system under increasing pressure and highlights the need for a wider debate around the spiralling diagnoses of ADHD and autism.

In just nine months Montrose has supported more than 200 clients through its ADHD and autism service. Jonathan and his team now have the capacity to treat 600 patients per month.

According to NHS figures referenced by Montrose, an estimated 2.5 million people in the UK are thought to have ADHD, while more than 562,000 NHS referrals for ADHD diagnosis remained open at the end of 2025. Autism referrals nationally have increased five-fold since 2009.

In April 2026, Montrose secured a Right to Choose contract with South Yorkshire Integrated Care Board to deliver ADHD and autism assessments and treatment for children aged six-plus alongside the provision of adult services.